ACH-3102
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ACH-3102, covering 2015-02-04 to 2015-02-04. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, and Efficacy of 12-weeks of Sovaprevir, ACH-3102, and Ribavirin in Treatment-naive GT-1 HCV Participants [Phase 2]